RN7SL477P

Across TCGA pan-cancer cohorts, RN7SL477P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RN7SL477P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RN7SL477P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL477P expression acts as an unfavorable survival marker, although some lineages such as STAD and UCS show a favorable association.

ACC, STAD, and UCS are the cancer types where RN7SL477P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.653	0.913	<.001	93	view →
STAD	OS	Tertile	III,IV	0.763	0.378	.011	32	view →
UCS	OS	Quartile	All	0.843	0.559	.018	30	view →
KIRC	DFS	Median	All	0.508	0.694	<.001	26	view →
KIRP	DFS	Median	II,III,IV	0.939	0.514	.010	23	view →
CHOL	DFS	Tertile	II,III,IV	0.114	0.754	.006	18	view →
UCEC	DFS	Median	III,IV	0.860	0.726	.004	16	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	15	view →
BRCA	OS	Quartile	II,III,IV	0.978	0.937	.026	13	view →
GBM	DFS	Median	All	0.389	0.190	.005	12	view →
UVM	OS	Tertile	II,III,IV	0.802	0.529	.040	12	view →
SKCM	DFS	Quartile	IV	0.040	0.854	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RN7SL477P–ACC (OS)

Open the ACC breakdown →